BIOPHARMX CORP's ticker is BPMX and the CUSIP is 09072X101. A total of 20 filers reported holding BIOPHARMX CORP in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $648,000 | +36.1% | 1,283,951 | +0.9% | 0.17% | -4.5% |
| Q4 2016 | $476,000 | +22.4% | 1,273,128 | +81.7% | 0.18% | +51.7% |
| Q3 2016 | $389,000 | -14.5% | 700,636 | 0.0% | 0.12% | -23.9% |
| Q2 2016 | $455,000 | -40.4% | 700,636 | 0.0% | 0.16% | -44.0% |
| Q1 2016 | $764,000 | +35.7% | 700,636 | +89.0% | 0.28% | +48.9% |
| Q4 2015 | $563,000 | +47.4% | 370,636 | 0.0% | 0.19% | +56.3% |
| Q3 2015 | $382,000 | -59.7% | 370,636 | 0.0% | 0.12% | -56.9% |
| Q2 2015 | $949,000 | – | 370,636 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 14,096,338 | $6,752,000 | 1.70% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 58,027 | $28,000 | 0.01% |
| Virtu KCG Holdings LLC | 503,418 | $241,000 | 0.01% |
| Baker Brothers Advisors | 598,758 | $287,000 | 0.00% |
| Moors & Cabot, Inc. | 40,000 | $19,000 | 0.00% |
| FRANKLIN RESOURCES INC | 9,499,615 | $4,550,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 11,385 | $5,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 323,967 | $155,000 | 0.00% |
| GUGGENHEIM CAPITAL LLC | 22,718 | $11,000 | 0.00% |
| OPPENHEIMER & CO INC | 28,000 | $13,000 | 0.00% |